[The improvement in the infectious safety of blood component therapy].
Zhiburt
E B
EB
Kas'ianov
A D
AD
D001769:Blood / Q000821:virology*; D016913:Blood Component Transfusion / Q000009:adverse effects / Q000592:standards*; D004266:DNA Virus Infections / Q000517:prevention & control / Q000635:transmission; D004267:DNA Viruses; D018067:Flaviviridae; D006518:Hepatitis Viruses; D006525:Hepatitis, Viral, Human / Q000517:prevention & control / Q000635:transmission; D019288:Herpesvirus 8, Human; D006801:Humans; D009103:Multiple Sclerosis / Q000821:virology; D012190:Retroviridae; D012192:Retroviridae Infections / Q000517:prevention & control / Q000635:transmission; D012449:Safety / Q000592:standards*; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000517:prevention & control